Related Experiment Video
Updated: Aug 14, 2026

Killer Artificial Antigen Presenting Cells (KaAPC) for Efficient In Vitro Depletion of Human Antigen-specific T Cells
Published on: August 12, 2014
LFG: an anti-apoptotic gene that provides protection from Fas-mediated cell death
N V Somia1, M J Schmitt, D E Vetter
1The Salk Institute for Biological Studies, 10010 North Torrey Pines Road, La Jolla, CA 92037, USA.
Abstract:
Programmed cell death regulates a number of biological phenomena, and the apoptotic signal must itself be tightly controlled to avoid inappropriate cell death. We established a genetic screen to search for molecules that inhibit the apoptotic signal from the Fas receptor. Here we report the isolation of a gene, LFG, that protects cells uniquely from Fas but not from the mechanistically related tumor necrosis factor alpha death signal. LFG is widely distributed, but remarkably is highly expressed in the hippocampus. LFG can bind to the Fas receptor, but does not regulate Fas expression or interfere with binding of an agonist antibody. Furthermore LFG does not inhibit binding of FADD to Fas.
Insights
Researchers identified a novel gene, LFG, that specifically inhibits the Fas receptor-mediated programmed cell death pathway. This discovery offers new insights into controlling apoptosis and has implications for neurological conditions due to high LFG expression in the hippocampus.
Area of Science:
- Cell Biology
- Molecular Biology
- Neuroscience
Background:
- Programmed cell death, or apoptosis, is a crucial biological process that must be tightly regulated.
- Dysregulation of apoptosis can lead to various pathological conditions.
- The Fas receptor is a key mediator of apoptosis, and its signaling pathway requires precise control.
Purpose of the Study:
- To identify novel molecules that can inhibit the apoptotic signaling initiated by the Fas receptor.
- To characterize the function and properties of newly discovered inhibitors of Fas-mediated apoptosis.
Main Methods:
- A genetic screen was employed to isolate genes that confer resistance to Fas-induced cell death.
- Expression analysis was performed to determine the tissue distribution of the identified gene.
- Biochemical assays were used to investigate the interaction of the gene product with the Fas receptor and its downstream signaling components.
Main Results:
- A novel gene, designated LFG, was isolated for its unique ability to protect cells from Fas-induced apoptosis.
- LFG specifically inhibits Fas-mediated death signaling, but not the related tumor necrosis factor alpha (TNF-α) pathway.
- LFG is expressed broadly, with particularly high levels detected in the hippocampus.
- LFG directly binds to the Fas receptor without affecting Fas expression, antibody binding, or FADD recruitment.
Conclusions:
- LFG is a novel inhibitor of Fas receptor-mediated apoptosis.
- The specific inhibition of Fas signaling by LFG suggests a targeted therapeutic potential.
- High expression of LFG in the hippocampus may indicate a role in neuronal protection or regulation of apoptosis in the central nervous system.
More Related Videos
Related Concept Videos
Apoptosis
Caspases
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Cellular Injury V: Apoptosis and Autophagy

